1. Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione
   Izabela Sadowska-Bartosz et al, 2016, Pharmacological Reports CrossRef
2. Impaired mitochondrial functions contribute to 3-bromopyruvate toxicity in primary rat and mouse hepatocytes
   Ondřej Sobotka et al, 2016, Journal of Bioenergetics and Biomembranes CrossRef
3. Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer
   Hsin-Chih Yeh et al, 2022, European Journal of Pharmacology CrossRef
4. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
   Li Yu et al, 2016, Oncotarget CrossRef
5. 3-Bromopyruvate induces expression of antioxidant genes
   Lukasz Pulaski et al, 2019, Free Radical Research CrossRef
6. Influence of high glucose state on bromopyruvate-induced cytotoxity by human colon cancer cell lines
   Masaya Ideno et al, 2016, Drug Metabolism and Pharmacokinetics CrossRef
7. NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells
   Jiajia Hu et al, 2015, Scientific Reports CrossRef
8. Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice
   Qiong Pan et al, 2016, Acta Cirurgica Brasileira CrossRef
9. Mitochondrial-targeted penetrating peptide delivery for cancer therapy
   Jiao Wu et al, 2018, Expert Opinion on Drug Delivery CrossRef
10. Multimodal Imaging of Pancreatic Cancer Microenvironment in Response to an Antiglycolytic Drug
    Elnaz Sheikh et al, 2023, Advanced Healthcare Materials CrossRef
11. Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma
    Raquel G. Coelho et al, 2015, Oncotarget CrossRef